SCHEMBL147860

SCHEMBL147860

[c]1ccc(Nc2ccncn2)cc1

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 11/20 0.44
▸ KDR P35968 2/20 0.44
▸ MKNK2 Q9HBH9 2/20 0.40
▸ GSK3A P49840 1/20 0.40
▸ CDK9 P50750 1/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ TAOK1 Q7L7X3 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ MPL P40238 2/20 0.38
▸ JAK2 O60674 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ TYK2 P29597 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14843891 0.84 MKNK1 (0.49) MKNK1KDRMKNK2GSK3ACDK9
SCHEMBL1323687 0.80 MAPT (0.53) MKNK1KDRCLK4MPL
SCHEMBL4630887 0.79 GSK3A (0.53) MKNK1KDRMKNK2GSK3ACDK9
SCHEMBL30611577 0.77 MEN1 (0.56) MKNK1MKNK2CLK4MPL
SCHEMBL4666187 0.77 RAD52 (0.59) MKNK1KDRMKNK2MPL
Hydrochloric Acid SCHEMBL7857018 0.77 GSK3A (0.51) MKNK1KDRMKNK2GSK3ACDK9
SCHEMBL147419 0.74 RAD52 (0.54) MKNK2GSK3ACLK4
SCHEMBL149380 0.74 MEN1 (0.55) KDR
SCHEMBL10586536 0.74 BCL6 (0.36) KDR
SCHEMBL23867504 0.73 RAB9A (0.46) MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8344142-B2 perylenetetracarboxylic diimide core having side chains (groups or mesogens) attached to the core; to provide charge-transport materials having various volatilities, solubilities, crystallinity, and charge transport ability; organic light emitting diode; photovoltaic cells, light-emitting diodes GEORGIA TECH RESEARCH CORPORATION (US) 2013-01-01 — — US claimed
US-8039625-B2 Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2011-10-18 — — US claimed
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF NATIONAL SCIENCE FOUNDATION 2009-02-19 — — US claimed
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof GEORGIA TECH RESEARCH CORPORATION 2008-09-18 — — US claimed
WO-2006093965-A2 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2006-09-08 — — WO claimed
WO-2005124453-A2 PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2005-12-29 — — WO claimed
CN-113330096-B Use of substituted or unsubstituted polycyclic aromatic compounds for high resolution microscopy 马克斯·普朗克索赔科学公司 2024-05-31 — — CN disclosed
US-11958796-B2 Hydrophilic and particularly water soluble DBOV-derivatives MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2024-04-16 — — US disclosed
CN-112839922-B Hydrophilic and in particular water-soluble DBOV derivatives 马克斯·普朗克索赔科学公司 2024-04-02 — — CN disclosed
EP-3830217-B1 USE OF A SUBSTITUTED OR UNSUBSTITUTED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND FOR HIGH-RESOLUTION MICROSCOPY MAX PLANCK GESELLSCHAFT (DE) 2022-07-20 — — EP disclosed
US-20220009870-A1 HYDROPHILIC AND PARTICULARLY WATER SOLUBLE DBOV-DERIVATIVES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-01-13 — — US disclosed
US-20210388260-A1 USE OF A SUBSTITUTED OR UNSUBSTITUTED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND FOR HIGH-RESOLUTION MICROSCOPY Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V (DE) 2021-12-16 — — US disclosed
EP-3649110-B1 MYCOBACTERIUM-TUBERCOLOSIS-THIOREDOXIN REDUCTASE INHIBITOR AS ANTITUBERCULOSIS DRUG UNIV DORTMUND TECH (DE) 2021-09-08 — — EP disclosed
US-5808073-A CATALYTIC AMINATION OF THE CORRESPONDING PERYLENETETRACARBOXYLIC ACID OR ANHYDRIDE WITH PRIMARY AMINE IN TERTIARY AMINE SOLVENT BASF AKTIENGESELLSCHAFT (DE) 1998-09-15 — — US disclosed
CN-1169155-A Substituted transannular tetracarboxylic acid diimide BASF AG (DE) 1997-12-31 — — CN disclosed
CN-1168151-A Process for producing and purifying perylene-3,4-dicarboxylic acid imides BASF AG (DE) 1997-12-17 — — CN disclosed
EP-0804508-A1 PROCESS FOR PRODUCING AND PURIFYING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF AKTIENGESELLSCHAFT (DE) 1997-11-05 — — EP disclosed
EP-0804507-A1 SUBSTITUTED QUATERRYLENE TETRACARBOXYLIC ACID DIIMIDES BASF AKTIENGESELLSCHAFT (DE) 1997-11-05 — — EP disclosed
WO-1996022332-A1 SUBSTITUTED QUATERRYLENE TETRACARBOXYLIC ACID DIIMIDES BASF AKTIENGESELLSCHAFT (DE) 1996-07-25 — — WO disclosed
WO-1996022331-A1 PROCESS FOR PRODUCING AND PURIFYING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF AKTIENGESELLSCHAFT (DE) 1996-07-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220009870-A1 HYDROPHILIC AND PARTICULARLY WATER SOLUBLE DBOV-DERIVATIVES NR1H4, HDGF, ABHD16A MKNK1 4792/4885KDR 13/4885MKNK2 4765/4885
US-20210388260-A1 USE OF A SUBSTITUTED OR UNSUBSTITUTED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND FOR HIGH-RESOLUTION MICROSCOPY AHR, ARNT, SAMM50 MKNK1 2603/4885KDR 1011/4885MKNK2 2860/4885
US-11958796-B2 Hydrophilic and particularly water soluble DBOV-derivatives NR1H4, HDGF, ABHD16A MKNK1 4792/4885KDR 13/4885MKNK2 4765/4885
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof SLC43A1, SLC3A2, SLC16A3 MKNK1 4122/4885KDR 519/4885MKNK2 3931/4885
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF SLC18A3, CORO1C, SLC18A1 MKNK1 4276/4885KDR 2375/4885MKNK2 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback